<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2237">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 19, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01057381</url>
  </required_header>
  <id_info>
    <org_study_id>H-17558</org_study_id>
    <nct_id>NCT01057381</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine in Pediatric Tonsillectomy</brief_title>
  <official_title>Dose Response Relationship of Dexmedetomidine in Decreasing Post Operative Analgesic Requirements in the Pediatric Tonsillectomy Patient</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baylor College of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of this study is that the administration of an intra-operative dose of&#xD;
      dexmedetomidine will result in adequate analgesia without respiratory depression thereby&#xD;
      resulting in an early discharge from the post anesthetic care unit following&#xD;
      adenotonsillectomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dexmedetomidine, an alpha 2 agonist provides some analgesia without respiratory depression.&#xD;
      Children undergoing tonsillectomy and adenoidectomy occasionally have episodes of respiratory&#xD;
      obstruction in the recovery room following administration of opioids.&#xD;
&#xD;
      As dexmedetomidine provides some analgesia without respiratory depression,an intra-operative&#xD;
      dose of dexmedetomidine may provide adequate analgesia without significant side effects&#xD;
      thereby allowing for quick post operative recovery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amount of Post-Operative Rescue Morphine Required for Analgesia</measure>
    <time_frame>From admission to discharge from PACU, up to 1 hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morphine Rescue Doses Needed by Participants</measure>
    <time_frame>From admission to discharge from PACU, up to 1 hour</time_frame>
    <description>Subjects with a Children's Hospital of Eastern Ontario Pain Scale score greater than 8 received rescue morphine doses of 25 ug/kg IV at 10-minute intervals until the score was less than 8.&#xD;
Minimum and Maximum values: minimum score: 4 &amp; maximum score: 13. The higher the score ( &gt; 8), the greater the pain appreciated by the patient.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Oxygen Supplementation</measure>
    <time_frame>From admission to PACU until room air saturations greater than or equal to 95% for 5 minutes</time_frame>
    <description>The subjects were then transported to the PACU with supplemental oxygen. Oxygen administration was continued after extubation until the patient was awake and could sustain room air saturations greater than 95% for 5 minutes. Duration of oxygen requirement was recorded as the time from tracheal extubation to cessation of oxygen supplementation in the PACU.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to PACU Discharge Readiness</measure>
    <time_frame>From admission to discharge from PACU, no time limit</time_frame>
    <description>Patients were considered ready for discharge from the PACU when they attained an Aldrete score of 9 or more and were free from pain, nausea, and vomiting. Aldrete score ranges form 0 to 10 and patients greater than 8 are deemed satisfactory for discharge from the PACU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Emergence Agitation</measure>
    <time_frame>From admission to discharge from PACU, no time limit</time_frame>
    <description>Patients in the PACU who were crying, restless, disoriented, unresponsive to the parent's voice, with non-purposeful thrashing movements requiring additional personnel to prevent bodily harm, and inconsolable even after parental presence, rescue analgesia and additional measures of comfort were considered to have emergence agitation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Postoperative Complications</measure>
    <time_frame>From admission to discharge from PACU, up to 1 hour</time_frame>
    <description>Post-operative complications including emesis, prolonged oxygen requirement or post- tonsillectomy bleed assessed up to 1 hour in PACU</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">109</enrollment>
  <condition>Pediatric Adenotonsillectomy</condition>
  <condition>Post Operative Analgesia</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine 0.75 mcg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intraoperative administration for analgesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine 1mcg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intra-operative administration of dexmedetomidine 1 mcg/kg for analgesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Morphine 50 mcg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intra-operative administration of morphine 50 mcg/kg for analgesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Morphine 100mcg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intra-operative administration of morphine 100mcg/kg for analgesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine 0.75 mcg/kg</intervention_name>
    <description>Single intra-operative administration of dexmedetomidine 0.75 mcg/kg over 10 minutes for analgesia.</description>
    <arm_group_label>Dexmedetomidine 0.75 mcg/kg</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine 50 mcg/kg</intervention_name>
    <description>Single intra-operative administration of morphine 50 mcg/kg over 10 minutes for analgesia</description>
    <arm_group_label>Morphine 50 mcg/kg</arm_group_label>
    <other_name>Morphine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine 100 mcg/kg</intervention_name>
    <description>Single intra-operative dose of morphine 100 mcg/kg over 10 minutes for analgesia</description>
    <arm_group_label>Morphine 100mcg/kg</arm_group_label>
    <other_name>Morphine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine 1 mcg/kg</intervention_name>
    <description>Single intra-operative administration of dexmedetomidine 1 mcg/kg over 10 minutes for analgesia</description>
    <arm_group_label>Dexmedetomidine 1mcg/kg</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children between ages 3 and 17 years with American Society of Anesthesiology&#xD;
             classification 1 or 2.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Children less than 3 years&#xD;
&#xD;
          -  Children with uncorrected cardiac lesions&#xD;
&#xD;
          -  Children with heart block or liver impairment&#xD;
&#xD;
          -  Children with American Society of Anesthesiology Class 3 or 4.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olutoyin A Olutoye, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Texas Children's Hospital, Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>January 25, 2010</study_first_submitted>
  <study_first_submitted_qc>January 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2010</study_first_posted>
  <results_first_submitted>January 12, 2021</results_first_submitted>
  <results_first_submitted_qc>January 12, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">February 1, 2021</results_first_posted>
  <last_update_submitted>July 23, 2021</last_update_submitted>
  <last_update_submitted_qc>July 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baylor College of Medicine</investigator_affiliation>
    <investigator_full_name>Olutoyin A. Olutoye</investigator_full_name>
    <investigator_title>Associate Professor of Anesthesiology &amp; Pediatrics</investigator_title>
  </responsible_party>
  <keyword>Adenotonsillectomy</keyword>
  <keyword>Postoperative analgesia</keyword>
  <keyword>Pediatrics</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 3, 2005</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/81/NCT01057381/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Dexmedetomidine 0.75 mcg/kg</title>
          <description>Intraoperative administration for analgesia.&#xD;
Dexmedetomidine 0.75 mcg/kg: Single intra-operative administration of dexmedetomidine 0.75 mcg/kg over 10 minutes for analgesia.</description>
        </group>
        <group group_id="P2">
          <title>Dexmedetomidine 1mcg/kg</title>
          <description>Intra-operative administration of dexmedetomidine 1 mcg/kg for analgesia&#xD;
Dexmedetomidine 1 mcg/kg: Single intra-operative administration of dexmedetomidine 1 mcg/kg over 10 minutes for analgesia</description>
        </group>
        <group group_id="P3">
          <title>Morphine 50 mcg/kg</title>
          <description>Intra-operative administration of morphine 50 mcg/kg for analgesia&#xD;
Morphine 50 mcg/kg: Single intra-operative administration of morphine 50 mcg/kg over 10 minutes for analgesia</description>
        </group>
        <group group_id="P4">
          <title>Morphine 100mcg/kg</title>
          <description>Intra-operative administration of morphine 100mcg/kg for analgesia&#xD;
Morphine 100 mcg/kg: Single intra-operative dose of morphine 100 mcg/kg over 10 minutes for analgesia</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="27"/>
                <participants group_id="P3" count="30"/>
                <participants group_id="P4" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="27"/>
                <participants group_id="P3" count="30"/>
                <participants group_id="P4" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Dexmedetomidine 0.75 mcg/kg</title>
          <description>Intraoperative administration for analgesia.&#xD;
Dexmedetomidine 0.75 mcg/kg: Single intra-operative administration of dexmedetomidine 0.75 mcg/kg over 10 minutes for analgesia.</description>
        </group>
        <group group_id="B2">
          <title>Dexmedetomidine 1mcg/kg</title>
          <description>Intra-operative administration of dexmedetomidine 1 mcg/kg for analgesia&#xD;
Dexmedetomidine 1 mcg/kg: Single intra-operative administration of dexmedetomidine 1 mcg/kg over 10 minutes for analgesia</description>
        </group>
        <group group_id="B3">
          <title>Morphine 50 mcg/kg</title>
          <description>Intra-operative administration of morphine 50 mcg/kg for analgesia&#xD;
Morphine 50 mcg/kg: Single intra-operative administration of morphine 50 mcg/kg over 10 minutes for analgesia</description>
        </group>
        <group group_id="B4">
          <title>Morphine 100mcg/kg</title>
          <description>Intra-operative administration of morphine 100mcg/kg for analgesia&#xD;
Morphine 100 mcg/kg: Single intra-operative dose of morphine 100 mcg/kg over 10 minutes for analgesia</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
            <count group_id="B2" value="27"/>
            <count group_id="B3" value="30"/>
            <count group_id="B4" value="26"/>
            <count group_id="B5" value="109"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="26"/>
                    <count group_id="B2" value="27"/>
                    <count group_id="B3" value="30"/>
                    <count group_id="B4" value="26"/>
                    <count group_id="B5" value="109"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="30"/>
                    <measurement group_id="B4" value="26"/>
                    <measurement group_id="B5" value="109"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="26"/>
                    <count group_id="B2" value="27"/>
                    <count group_id="B3" value="30"/>
                    <count group_id="B4" value="26"/>
                    <count group_id="B5" value="109"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="16"/>
                    <measurement group_id="B5" value="65"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                    <count group_id="B5" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="26"/>
                    <count group_id="B2" value="27"/>
                    <count group_id="B3" value="30"/>
                    <count group_id="B4" value="26"/>
                    <count group_id="B5" value="109"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="30"/>
                    <measurement group_id="B4" value="26"/>
                    <measurement group_id="B5" value="109"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of Surgery</title>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="26"/>
                    <count group_id="B2" value="27"/>
                    <count group_id="B3" value="30"/>
                    <count group_id="B4" value="26"/>
                    <count group_id="B5" value="109"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.0" spread="8.4"/>
                    <measurement group_id="B2" value="21.3" spread="9.7"/>
                    <measurement group_id="B3" value="22.8" spread="7.6"/>
                    <measurement group_id="B4" value="26.0" spread="9.5"/>
                    <measurement group_id="B5" value="23.0" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of Anesthesia</title>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="26"/>
                    <count group_id="B2" value="27"/>
                    <count group_id="B3" value="30"/>
                    <count group_id="B4" value="26"/>
                    <count group_id="B5" value="109"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.2" spread="19.3"/>
                    <measurement group_id="B2" value="44.7" spread="10.8"/>
                    <measurement group_id="B3" value="43.3" spread="9.7"/>
                    <measurement group_id="B4" value="49.6" spread="13.3"/>
                    <measurement group_id="B5" value="46.3" spread="13.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Amount of Post-Operative Rescue Morphine Required for Analgesia</title>
        <time_frame>From admission to discharge from PACU, up to 1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexmedetomidine 0.75 mcg/kg</title>
            <description>Intraoperative administration for analgesia.&#xD;
Dexmedetomidine 0.75 mcg/kg: Single intra-operative administration of dexmedetomidine 0.75 mcg/kg over 10 minutes for analgesia.</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine 1mcg/kg</title>
            <description>Intra-operative administration of dexmedetomidine 1 mcg/kg for analgesia&#xD;
Dexmedetomidine 1 mcg/kg: Single intra-operative administration of dexmedetomidine 1 mcg/kg over 10 minutes for analgesia</description>
          </group>
          <group group_id="O3">
            <title>Morphine 50 mcg/kg</title>
            <description>Intra-operative administration of morphine 50 mcg/kg for analgesia&#xD;
Morphine 50 mcg/kg: Single intra-operative administration of morphine 50 mcg/kg over 10 minutes for analgesia</description>
          </group>
          <group group_id="O4">
            <title>Morphine 100mcg/kg</title>
            <description>Intra-operative administration of morphine 100mcg/kg for analgesia&#xD;
Morphine 100 mcg/kg: Single intra-operative dose of morphine 100 mcg/kg over 10 minutes for analgesia</description>
          </group>
        </group_list>
        <measure>
          <title>Amount of Post-Operative Rescue Morphine Required for Analgesia</title>
          <units>ug/kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="30"/>
                <count group_id="O4" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.2" spread="30.8"/>
                    <measurement group_id="O2" value="37.0" spread="25.4"/>
                    <measurement group_id="O3" value="43.3" spread="23.6"/>
                    <measurement group_id="O4" value="36.5" spread="31.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Morphine Rescue Doses Needed by Participants</title>
        <description>Subjects with a Children's Hospital of Eastern Ontario Pain Scale score greater than 8 received rescue morphine doses of 25 ug/kg IV at 10-minute intervals until the score was less than 8.&#xD;
Minimum and Maximum values: minimum score: 4 &amp; maximum score: 13. The higher the score ( &gt; 8), the greater the pain appreciated by the patient.</description>
        <time_frame>From admission to discharge from PACU, up to 1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexmedetomidine 0.75 mcg/kg</title>
            <description>Intraoperative administration for analgesia.&#xD;
Dexmedetomidine 0.75 mcg/kg: Single intra-operative administration of dexmedetomidine 0.75 mcg/kg over 10 minutes for analgesia.</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine 1mcg/kg</title>
            <description>Intra-operative administration of dexmedetomidine 1 mcg/kg for analgesia&#xD;
Dexmedetomidine 1 mcg/kg: Single intra-operative administration of dexmedetomidine 1 mcg/kg over 10 minutes for analgesia</description>
          </group>
          <group group_id="O3">
            <title>Morphine 50 mcg/kg</title>
            <description>Intra-operative administration of morphine 50 mcg/kg for analgesia&#xD;
Morphine 50 mcg/kg: Single intra-operative administration of morphine 50 mcg/kg over 10 minutes for analgesia</description>
          </group>
          <group group_id="O4">
            <title>Morphine 100mcg/kg</title>
            <description>Intra-operative administration of morphine 100mcg/kg for analgesia&#xD;
Morphine 100 mcg/kg: Single intra-operative dose of morphine 100 mcg/kg over 10 minutes for analgesia</description>
          </group>
        </group_list>
        <measure>
          <title>Morphine Rescue Doses Needed by Participants</title>
          <description>Subjects with a Children's Hospital of Eastern Ontario Pain Scale score greater than 8 received rescue morphine doses of 25 ug/kg IV at 10-minute intervals until the score was less than 8.&#xD;
Minimum and Maximum values: minimum score: 4 &amp; maximum score: 13. The higher the score ( &gt; 8), the greater the pain appreciated by the patient.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="30"/>
                <count group_id="O4" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 dose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 dose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;1 dose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="16"/>
                    <measurement group_id="O4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Oxygen Supplementation</title>
        <description>The subjects were then transported to the PACU with supplemental oxygen. Oxygen administration was continued after extubation until the patient was awake and could sustain room air saturations greater than 95% for 5 minutes. Duration of oxygen requirement was recorded as the time from tracheal extubation to cessation of oxygen supplementation in the PACU.</description>
        <time_frame>From admission to PACU until room air saturations greater than or equal to 95% for 5 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexmedetomidine 0.75 mcg/kg</title>
            <description>Intraoperative administration for analgesia.&#xD;
Dexmedetomidine 0.75 mcg/kg: Single intra-operative administration of dexmedetomidine 0.75 mcg/kg over 10 minutes for analgesia.</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine 1mcg/kg</title>
            <description>Intra-operative administration of dexmedetomidine 1 mcg/kg for analgesia&#xD;
Dexmedetomidine 1 mcg/kg: Single intra-operative administration of dexmedetomidine 1 mcg/kg over 10 minutes for analgesia</description>
          </group>
          <group group_id="O3">
            <title>Morphine 50 mcg/kg</title>
            <description>Intra-operative administration of morphine 50 mcg/kg for analgesia&#xD;
Morphine 50 mcg/kg: Single intra-operative administration of morphine 50 mcg/kg over 10 minutes for analgesia</description>
          </group>
          <group group_id="O4">
            <title>Morphine 100mcg/kg</title>
            <description>Intra-operative administration of morphine 100mcg/kg for analgesia&#xD;
Morphine 100 mcg/kg: Single intra-operative dose of morphine 100 mcg/kg over 10 minutes for analgesia</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Oxygen Supplementation</title>
          <description>The subjects were then transported to the PACU with supplemental oxygen. Oxygen administration was continued after extubation until the patient was awake and could sustain room air saturations greater than 95% for 5 minutes. Duration of oxygen requirement was recorded as the time from tracheal extubation to cessation of oxygen supplementation in the PACU.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="30"/>
                <count group_id="O4" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17" spread="11"/>
                    <measurement group_id="O2" value="19" spread="12"/>
                    <measurement group_id="O3" value="20" spread="19"/>
                    <measurement group_id="O4" value="18" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to PACU Discharge Readiness</title>
        <description>Patients were considered ready for discharge from the PACU when they attained an Aldrete score of 9 or more and were free from pain, nausea, and vomiting. Aldrete score ranges form 0 to 10 and patients greater than 8 are deemed satisfactory for discharge from the PACU</description>
        <time_frame>From admission to discharge from PACU, no time limit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexmedetomidine 0.75 mcg/kg</title>
            <description>Intraoperative administration for analgesia.&#xD;
Dexmedetomidine 0.75 mcg/kg: Single intra-operative administration of dexmedetomidine 0.75 mcg/kg over 10 minutes for analgesia.</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine 1mcg/kg</title>
            <description>Intra-operative administration of dexmedetomidine 1 mcg/kg for analgesia&#xD;
Dexmedetomidine 1 mcg/kg: Single intra-operative administration of dexmedetomidine 1 mcg/kg over 10 minutes for analgesia</description>
          </group>
          <group group_id="O3">
            <title>Morphine 50 mcg/kg</title>
            <description>Intra-operative administration of morphine 50 mcg/kg for analgesia&#xD;
Morphine 50 mcg/kg: Single intra-operative administration of morphine 50 mcg/kg over 10 minutes for analgesia</description>
          </group>
          <group group_id="O4">
            <title>Morphine 100mcg/kg</title>
            <description>Intra-operative administration of morphine 100mcg/kg for analgesia&#xD;
Morphine 100 mcg/kg: Single intra-operative dose of morphine 100 mcg/kg over 10 minutes for analgesia</description>
          </group>
        </group_list>
        <measure>
          <title>Time to PACU Discharge Readiness</title>
          <description>Patients were considered ready for discharge from the PACU when they attained an Aldrete score of 9 or more and were free from pain, nausea, and vomiting. Aldrete score ranges form 0 to 10 and patients greater than 8 are deemed satisfactory for discharge from the PACU</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="30"/>
                <count group_id="O4" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="115" spread="0.04"/>
                    <measurement group_id="O2" value="116" spread="0.03"/>
                    <measurement group_id="O3" value="117" spread="0.03"/>
                    <measurement group_id="O4" value="122" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Emergence Agitation</title>
        <description>Patients in the PACU who were crying, restless, disoriented, unresponsive to the parent's voice, with non-purposeful thrashing movements requiring additional personnel to prevent bodily harm, and inconsolable even after parental presence, rescue analgesia and additional measures of comfort were considered to have emergence agitation.</description>
        <time_frame>From admission to discharge from PACU, no time limit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexmedetomidine 0.75 mcg/kg</title>
            <description>Intraoperative administration for analgesia.&#xD;
Dexmedetomidine 0.75 mcg/kg: Single intra-operative administration of dexmedetomidine 0.75 mcg/kg over 10 minutes for analgesia.</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine 1mcg/kg</title>
            <description>Intra-operative administration of dexmedetomidine 1 mcg/kg for analgesia&#xD;
Dexmedetomidine 1 mcg/kg: Single intra-operative administration of dexmedetomidine 1 mcg/kg over 10 minutes for analgesia</description>
          </group>
          <group group_id="O3">
            <title>Morphine 50 mcg/kg</title>
            <description>Intra-operative administration of morphine 50 mcg/kg for analgesia&#xD;
Morphine 50 mcg/kg: Single intra-operative administration of morphine 50 mcg/kg over 10 minutes for analgesia</description>
          </group>
          <group group_id="O4">
            <title>Morphine 100mcg/kg</title>
            <description>Intra-operative administration of morphine 100mcg/kg for analgesia&#xD;
Morphine 100 mcg/kg: Single intra-operative dose of morphine 100 mcg/kg over 10 minutes for analgesia</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Emergence Agitation</title>
          <description>Patients in the PACU who were crying, restless, disoriented, unresponsive to the parent's voice, with non-purposeful thrashing movements requiring additional personnel to prevent bodily harm, and inconsolable even after parental presence, rescue analgesia and additional measures of comfort were considered to have emergence agitation.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="30"/>
                <count group_id="O4" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Postoperative Complications</title>
        <description>Post-operative complications including emesis, prolonged oxygen requirement or post- tonsillectomy bleed assessed up to 1 hour in PACU</description>
        <time_frame>From admission to discharge from PACU, up to 1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexmedetomidine 0.75 mcg/kg</title>
            <description>Intraoperative administration for analgesia.&#xD;
Dexmedetomidine 0.75 mcg/kg: Single intra-operative administration of dexmedetomidine 0.75 mcg/kg over 10 minutes for analgesia.</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine 1mcg/kg</title>
            <description>Intra-operative administration of dexmedetomidine 1 mcg/kg for analgesia&#xD;
Dexmedetomidine 1 mcg/kg: Single intra-operative administration of dexmedetomidine 1 mcg/kg over 10 minutes for analgesia</description>
          </group>
          <group group_id="O3">
            <title>Morphine 50 mcg/kg</title>
            <description>Intra-operative administration of morphine 50 mcg/kg for analgesia&#xD;
Morphine 50 mcg/kg: Single intra-operative administration of morphine 50 mcg/kg over 10 minutes for analgesia</description>
          </group>
          <group group_id="O4">
            <title>Morphine 100mcg/kg</title>
            <description>Intra-operative administration of morphine 100mcg/kg for analgesia&#xD;
Morphine 100 mcg/kg: Single intra-operative dose of morphine 100 mcg/kg over 10 minutes for analgesia</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Postoperative Complications</title>
          <description>Post-operative complications including emesis, prolonged oxygen requirement or post- tonsillectomy bleed assessed up to 1 hour in PACU</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="30"/>
                <count group_id="O4" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Nausea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Subjects were monitored from beginning of surgery until discharge from Post-Anesthetic Care Unit (PACU). There was no time limit on time monitored.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Dexmedetomidine 0.75 mcg/kg</title>
          <description>Intraoperative administration for analgesia.&#xD;
Dexmedetomidine 0.75 mcg/kg: Single intra-operative administration of dexmedetomidine 0.75 mcg/kg over 10 minutes for analgesia.</description>
        </group>
        <group group_id="E2">
          <title>Dexmedetomidine 1mcg/kg</title>
          <description>Intra-operative administration of dexmedetomidine 1 mcg/kg for analgesia&#xD;
Dexmedetomidine 1 mcg/kg: Single intra-operative administration of dexmedetomidine 1 mcg/kg over 10 minutes for analgesia</description>
        </group>
        <group group_id="E3">
          <title>Morphine 50 mcg/kg</title>
          <description>Intra-operative administration of morphine 50 mcg/kg for analgesia&#xD;
Morphine 50 mcg/kg: Single intra-operative administration of morphine 50 mcg/kg over 10 minutes for analgesia</description>
        </group>
        <group group_id="E4">
          <title>Morphine 100mcg/kg</title>
          <description>Intra-operative administration of morphine 100mcg/kg for analgesia&#xD;
Morphine 100 mcg/kg: Single intra-operative dose of morphine 100 mcg/kg over 10 minutes for analgesia</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>We studied a relatively healthy patient population and excluded children with documented sleep apnea by polysomnography.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Olutoyin A. Olutoye, M.D., M.Sc.</name_or_title>
      <organization>Baylor College of Medicine</organization>
      <phone>(832) 824-5800</phone>
      <email>oao@bcm.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

